Analyze Diet
Pulmonary pharmacology & therapeutics2019; 59; 101849; doi: 10.1016/j.pupt.2019.101849

Isolated airways in equine respiratory pharmacology: They never lie.

Abstract: Pre-clinical studies on human isolated bronchi have relevant translational value in human in vivo, conversely no investigation has been performed to assess whether data resulting from equine isolated airways can have any translational application in asthmatic horses. Thus, a meta-regression analysis via random-effect method was carried out to correlate the pharmacological characteristics of bronchodilators resulting from experiments performed in equine isolated bronchi with their impact on the lung function outcomes in asthmatic horses. Data on the potency of different bronchodilators were extracted from four ex vivo studies involving 68 horses, and related with the maximum change in transpulmonary pressure (ΔPpl), pulmonary resistance (R), and dynamic lung compliance (C) resulting from the meta-analysis of clinical trials aimed to assess the effect of different bronchodilator classes, namely antimuscarinic agents and β-adrenoreceptor (β-AR) agonists, on lung function of asthmatic horses. The potency (pEC) detected in equine isolated bronchi for each specific bronchodilator did not significantly (P > 0.05) influence the bronchorelaxant effect resulting from clinical trials. R was characterized by a flatter meta-regression line (slope 0.01, 95%CI -0.25 - 0.28) with respect to ΔPpl (slope 0.90, 95%CI -4.06 - 2.26) and C (slope 0.09, 95%CI -0.21 - 0.04). The quality of evidence was moderate for R and ΔPpl and low for C. This quantitative synthesis provides the indirect evidence that pre-clinical investigations performed by using equine isolated airways may produce useful data to predict the impact of bronchodilators on the R of asthmatic horses. Further translational studies are needed to directly confirm the results of this research.
Publication Date: 2019-09-22 PubMed ID: 31553927DOI: 10.1016/j.pupt.2019.101849Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates if data from equine isolated airways have any application in treating asthmatic horses. This comprehensive study combines findings from different bronchodilators and evaluates their impact on the respiratory function of horses with asthma, suggesting that pre-clinical investigations using equine isolated airways can be useful.

Background and Aim

  • This research is focused on understanding and evaluating the translational value of studies performed on isolated airways in horses, specifically as it applies to the treatment of asthmatic horses.
  • The goal is to assess how the pharmacological characteristics of bronchodilators, extracted from studies, directly affect the lung functions outcomes in asthmatic horses. It raises the question of whether these ‘in vitro’ studies provide useful data in predicting how these bronchodilators would perform ‘in vivo’.

Methodology

  • The researchers used a meta-regression analysis via a random-effect method to correlate results from in vitro studies with in vivo results. This is a statistical model used to analyze the relationships between study data and the effects of different conditions or treatments.
  • Data regarding the potency of distinct bronchodilators were extracted from four ex vivo studies involving 68 horses. These data were then connected to parameters including changes in the transpulmonary pressure, pulmonary resistance, and dynamic lung compliance.

Findings

  • The potency of each bronchodilator, as detected in equine isolated bronchi, did not significantly influence the bronchodilatory effect seen in clinical trials.
  • The pulmonary resistance had a flatter line of meta-regression compared to pulmonary pressure and dynamic lung compliance. This could potentially mean that the bronchodilators’ effect on resistance was relatively consistent regardless of their observed in vitro potency.
  • The quality of evidence was termed moderate for pulmonary resistance and pressure change while low for lung compliance. This indicates the need for further confirmatory studies.

Conclusion

  • The findings suggest that pre-clinical investigations carried out using equine isolated airways can produce useful data for predicting the bronchodilators’ impact on the pulmonary resistance of asthmatic horses.
  • However, further translational studies are required to confirm the results of this research due to the varying quality of evidence.

Cite This Article

APA
(2019). Isolated airways in equine respiratory pharmacology: They never lie. Pulm Pharmacol Ther, 59, 101849. https://doi.org/10.1016/j.pupt.2019.101849

Publication

ISSN: 1522-9629
NlmUniqueID: 9715279
Country: England
Language: English
Volume: 59
Pages: 101849
PII: S1094-5539(19)30209-3

Researcher Affiliations

MeSH Terms

  • Adrenergic beta-2 Receptor Agonists / administration & dosage
  • Adrenergic beta-2 Receptor Agonists / pharmacology
  • Animals
  • Asthma / drug therapy
  • Asthma / veterinary
  • Bronchi / drug effects
  • Bronchodilator Agents / administration & dosage
  • Bronchodilator Agents / pharmacology
  • Horse Diseases / drug therapy
  • Horse Diseases / physiopathology
  • Horses
  • Muscarinic Antagonists / administration & dosage
  • Muscarinic Antagonists / pharmacology

Citations

This article has been cited 2 times.
  1. Calzetta L, Chetta A, Aiello M, Frizzelli A, Ora J, Melis E, Facciolo F, Ippoliti L, Magrini A, Rogliani P. The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma. Vaccines (Basel) 2023 Jan 28;11(2).
    doi: 10.3390/vaccines11020282pubmed: 36851160google scholar: lookup
  2. Ritondo BL, Rogliani P, Facciolo F, Falco S, Vocale A, Calzetta L. Beclomethasone dipropionate and sodium cromoglycate protect against airway hyperresponsiveness in a human ex vivo model of cow's milk aspiration. Curr Res Pharmacol Drug Discov 2021;2:100010.
    doi: 10.1016/j.crphar.2020.100010pubmed: 34909646google scholar: lookup